Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis
Geoffroy Venton(Inserm), Régis Costello(Inserm), Yasmine Labiad(Inserm), Pascal Rihet(Aix-Marseille Université), Nicolas Fernandez(Inserm), Aurore Fino(Inserm), Céline Baier(Inserm), Sarwat Afridi(Inserm), Béatrice Loriod(Inserm), Laure Farnault(Aix-Marseille Université), Aurélie Bergon(Inserm), Julien Colle(Inserm), Jean Camille Mattei(Inserm), Catherine Nguyen(Cooper Medical School of Rowan University), M. Torres(Inserm), S. Monteuil(Inserm), Pierre Suchon(Inserm)
Cited by 18
Related Papers
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
|Journal of the American Heart Association|2020|298
Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous Thromboembolism
|The American Journal of Human Genetics|2015|274
Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism
|Blood|2019|238
Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels
|Circulation|2019|170
Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes
|Circulation Genomic and Precision Medicine|2020|170